Cite
HARVARD Citation
Doua, J. et al. (n.d.). 120. Safety, Reactogenicity, and Immunogenicity of Three Different Doses of VAC52416 (ExPEC10V) in Adults Aged 60–85 Years in a Randomized, Multicenter, Interventional, First-In-Human, Phase 1/2a Study. Open forum infectious diseases. p. . [Online].